[HTML][HTML] Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

SK Elledge, XX Zhou, JR Byrnes, AJ Martinko… - Nature …, 2021 - nature.com
Current serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antibodies mainly take the form of enzyme-linked immunosorbent assays, chemiluminescent …

[引用][C] Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

SK Elledge, XX Zhou, JR Byrnes, AJ Martinko… - Nature …, 2021 - cir.nii.ac.jp
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

SK Elledge, XX Zhou, JR Byrnes, AJ Martinko, I Lui… - medRxiv, 2020 - medrxiv.org
Current serology tests for SARS-CoV-2 antibodies mainly take the form of enzyme-linked
immunosorbent assays or lateral flow assays, with the former being laborious and the latter …

[HTML][HTML] Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

SK Elledge, XX Zhou, JR Byrnes, AJ Martinko… - Nature …, 2021 - ncbi.nlm.nih.gov
Current serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antibodies mainly take the form of enzyme-linked immunosorbent assays, chemiluminescent …

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.

SK Elledge, XX Zhou, JR Byrnes, AJ Martinko… - Nature …, 2021 - escholarship.org
Current serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antibodies mainly take the form of enzyme-linked immunosorbent assays, chemiluminescent …

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

SK Elledge, XX Zhou, JR Byrnes, AJ Martinko, I Lui… - 2020 - pesquisa.bvsalud.org
Current serology tests for SARS-CoV-2 antibodies mainly take the form of enzyme-linked
immunosorbent assays or lateral flow assays, with the former being laborious and the latter …

[HTML][HTML] Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

SK Elledge, XX Zhou, JR Byrnes, AJ Martinko, I Lui… - 2020 - europepmc.org
Current serology tests for SARS-CoV-2 antibodies mainly take the form of enzyme-linked
immunosorbent assays or lateral flow assays, with the former being laborious and the latter …

[PDF][PDF] Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

SK Elledge, XX Zhou, JR Byrnes, AJ Martinko, I Lui… - academia.edu
Fig. 1| Engineering luminescent biosensors for rapid and quantitative detection of SARS-
CoV-2 antibodies. a, Schematic of the solution-based serology assay. Patient antibodies are …

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

SK Elledge, XX Zhou, JR Byrnes… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Current serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antibodies mainly take the form of enzyme-linked immunosorbent assays, chemiluminescent …

[PDF][PDF] Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody 1 detection 2

SK Elledge, XX Zhou, JR Byrnes, AJ Martinko, I Lui… - scienceopen.com
Current serology tests for SARS-CoV-2 antibodies mainly take the form of enzyme-linked 29
immunosorbent assays or lateral flow assays, with the former being laborious and the latter …